Sustained retroviral gene marking and expression in lymphoid and myeloid cells derived from transduced hematopoietic progenitor cells

Gene Therapy

Volumn 3, Issue 8, 1996, Pages 717-724

  Plavec, I ^a   Voytovich, A ^a   Moss, K ^a   Webster, D ^a,b   Hanley, M B ^a,b   Escaich, S ^a   Ho, K E ^a,c   Bohnlein E ^a   DiGiusto, D L ^a,d  

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GENENTECH INC   (United States)

^d Sirna Therapeutics Inc   (United States)

Author keywords

Expression; Gene therapy; HIV 1; Retroviral vector; Stem cells

Indexed keywords

ANTIVIRUS AGENT; CD14 ANTIGEN; CD34 ANTIGEN; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; COLONY FORMATION; CONTROLLED STUDY; EXPRESSION VECTOR; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; T LYMPHOCYTE; THYMUS; UMBILICAL CORD BLOOD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; ANTIGENS, CD34; BONE MARROW; BONE MARROW CELLS; FETAL BLOOD; GENE EXPRESSION; GENE THERAPY; GENETIC MARKERS; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOID TISSUE; MICE; MICE, SCID; POLYMERASE CHAIN REACTION; RETROVIRIDAE; T-LYMPHOCYTES; TISSUE TRANSPLANTATION; TRANSDUCTION, GENETIC;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; UNIDENTIFIED RETROVIRUS;

EID: 0029782756     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Brenner MK. Human somatic gene therapy: progress and problems. J Intern Med 1995; 237: 229-239.
2. Miller AD. Human gene therapy comes of age. Nature 1992; 357: 455-460.
3. Hock RA, Miller AD. Retrovirus mediated transfer and expression of drug resistance genes in human hematopoietic progenitors. Nature 1986; 320: 275-277.
4. Hogge DE, Humphries RK. Gene transfer to primary normal and malignant human hematopoietic progenitors using recombinant retrovirus. Blood 1987; 69: 611-617.
5. Moore KA et al. Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture-initiating cells. Blood 1992; 79: 1393-1399.
6. Moritz T, Keller DC, Williams DA. Human cord blood cells as targets for gene transfer: potential use in genetic therapies of severe combined immunodeficiency disease. J Exp Med 1993; 178: 529-536.
7. Moritz T, Patel VP, Williams DA. Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retrovirus vectors. J Clin Invest 1994; 93: 1451-1457.
8. Cournoyer D et al. Gene transfer of adenosine deaminase into primitive human hematopoietic progenitor cells. Hum Gene Ther 1991; 2: 203-213.
9. Dunbar CE et al. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 1995; 85: 3048-3057.
10. Deisseroth AB et al. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 1994; 83: 3068-3076.
11. Rill DR et al. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 1994; 84: 380-383.
12. Harris DT et al. Collection, separation and cryopreservation of umbilical cord blood for use in transplantation. Bone Marrow Transplant 1993; 13: 135-143.
13. + cells purified using a novel O-sialoglycoprotease. Leukemia 1992; 6: 926-934.
14. DiGiusto DL et al. Hematopoietic potential of cryopreserved and ex vivo manipulated cord blood progenitors evaluated in vitro and in vivo. Blood 1996; 87: 1261-1271.
15. Nolta JA, Kohn DB. Comparison of the effects of growth factors on retroviral-mediated gene transfer and proliferative status of human hematopoietic progenitor cells. Hum Gene Ther 1990; 1: 257-268.
16. Forestell SP, Böhnlein E, Rigg RJ. Retroviral end-point titer is not predictive of gene transfer efficiency: implications for vector production. Gene Therapy 1995; 2: 723-730.
17. James SP. Measurement of proliferative responses of cultured lymphocytes. In: Coico R (ed). Current Protocols in Immunology, vol. 1. John Wiley & Sons: New York, 1994.
18. Nabel GJ et al. A molecular genetic intervention for AIDS - effects of a transdominant negative form of Rev. Hum Gene Ther 1995; 5: 79-92.
19. + hematopoietic stem/progenitor cells from human umbilical cord blood. J Exp Med 1993; 178: 2089-2096.
20. Nolta JA, Smogorzewska EM, Kohn DB. Analysis of optimal conditions for retroviral-mediated transduction of primitive hematopoietic cells. Blood 1995; 86: 101-110.
21. Akkina RK et al. Modeling human lymphoid precursor cell gene therapy in the SCID-hu mouse. Blood 1994; 84: 1393-1398.
22. Kotani H et al. Improved method of retroviral vector transduction and production for gene therapy. Hum Gene Ther 1994; 5: 19-28.
23. Bahnson AB et al. Centrifugal enhancement of retroviral-mediated gene-transfer. J Virol Methods 1995; 54: 131-143.
24. Naviaux RK, Verma IM. Retroviral vectors for persistent expression in vivo. Current Opin Bioteck 1992; 3: 540-547.
25. Escaich S et al. RevM10-mediated inhibition of HIV-1 replication in chronically infected T cells. Hum Gene Ther 1995; 6: 625-634.
26. Chu G, Hayakawa H, Berg P. Electroporation for the efficient transfection of mammalian cells with DNA. Nucleic Acids Res 1987; 15: 1311-1326.
27. Miller AD, Buttimore C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 1986; 6: 2895-2902.
28. Markowitz D, Goff S, Bank A. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol 1988; 62: 1120-1124.
29. Mann R, Mulligan RC, Baltimore D. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 1983; 33: 153-159.
30. Haapala DK et al. Isolation from cats of an endogenous type C virus with a novel glycoprotein. J Virol 1985; 53: 827-833.
31. Baum CM et al. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 1992; 89: 2804-2808.